The galactosaminoglycan-containing decorin and its impact on diseases

Current Opinion in Structural Biology

Volumn 22, Issue 5, 2012, Pages 578-582

  Seidler, Daniela G ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DECORIN; DERMATAN SULFATE; GALACTOSAMINOGLYCAN; GROWTH FACTOR;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CARBOHYDRATE SYNTHESIS; CELL GROWTH; CONFORMATIONAL TRANSITION; CONGENITAL CORNEA DYSTROPHY; CONNECTIVE TISSUE DISEASE; DISEASE ASSOCIATION; EHLERS DANLOS SYNDROME; EXTRACELLULAR MATRIX; GENE MUTATION; GROWTH REGULATION; HUMAN; IMMUNITY; MOLECULAR PATHOLOGY; MORPHOGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; DECORIN; DISEASE; HUMANS; POLYSACCHARIDES; REPETITIVE SEQUENCES, AMINO ACID;

EID: 84867745182     PISSN: 0959440X     EISSN: 1879033X     Source Type: Journal    
DOI: 10.1016/j.sbi.2012.07.012     Document Type: Review

References (52)

1. McEwan P.A., Scott P.G., Bishop P.N., Bella J. Structural correlations in the family of small leucine-rich repeat proteins and proteoglycans. J Struct Biol 2006, 155:294-305.
2. Pacheco B., Maccarana M., Malmstrom A. Dermatan 4-O-sulfotransferase 1 is pivotal in the formation of iduronic acid blocks in dermatan sulfate. Glycobiology 2009, 19:1197-1203.
3. Pacheco B., Malmstrom A., Maccarana M. Two dermatan sulfate epimerases form iduronic acid domains in dermatan sulfate. J Biol Chem 2009, 284:9788-9795.
4. Ferro D.R., Provasoli A., Ragazzi M., Casu B., Torri G., Bossennec V., Perly B., Sinay P., Petitou M., Choay J. Conformer populations of l-iduronic acid residues in glycosaminoglycan sequences. Carbohydr Res 1990, 195:157-167.
5. Kalamajski S., Oldberg A. The role of small leucine-rich proteoglycans in collagen fibrillogenesis. Matrix Biol 2010, 29:248-253.
6. Schaefer L., Iozzo R.V. Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction. J Biol Chem 2008, 283:21305-21309.
7. Hayes A.J., Tudor D., Nowell M.A., Caterson B., Hughes C.E. Chondroitin sulfate sulfation motifs as putative biomarkers for isolation of articular cartilage progenitor cells. J Histochem Cytochem 2008, 56:125-138.
8. Danielson K.G., Baribault H., Holmes D.F., Graham H., Kadler K.E., Iozzo R.V. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 1997, 136:729-743.
9. Ameye L., Young M.F. Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology 2002, 12:107R-116R.
10. Bredrup C., Knappskog P.M., Majewski J., Rodahl E., Boman H. Congenital stromal dystrophy of the cornea caused by a mutation in the decorin gene. Invest Ophthalmol Vis Sci 2005, 46:420-426.
11. Zhang G., Chen S., Goldoni S., Calder B.W., Simpson H.C., Owens R.T., McQuillan D.J., Young M.F., Iozzo R.V., Birk D.E. Genetic evidence for the coordinated regulation of collagen fibrillogenesis in the cornea by decorin and biglycan. J Biol Chem 2009, 284:8888-8897.
12. Chen S., Sun M., Meng X., Iozzo R.V., Kao W.W., Birk D.E. Pathophysiological mechanisms of autosomal dominant congenital stromal corneal dystrophy: C-terminal-truncated decorin results in abnormal matrix assembly and altered expression of small leucine-rich proteoglycans. Am J Pathol 2011, 179:2409-2419.
13. Iozzo R.V., Sanderson R.D. Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. J Cell Mol Med 2011, 15:1013-1031.
14. Schönherr E., Sunderkötter C., Iozzo R.V., Schaefer L. Decorin, a novel player in the insulin-like growth factor system. J Biol Chem 2005, 280:15767-15772.
15. Iozzo R.V., Buraschi S., Genua M., Xu S.Q., Solomides C.C., Peiper S.C., Gomella L.G., Owens R.C., Morrione A. Decorin antagonizes IGF receptor I (IGF-IR) function by interfering with IGF-IR activity and attenuating downstream signaling. J Biol Chem 2011, 286:34712-34721.
16. Goldoni S., Humphries A., Nystrom A., Sattar S., Owens R.T., McQuillan D.J., Ireton K., Iozzo R.V. Decorin is a novel antagonistic ligand of the Met receptor. J Cell Biol 2009, 185:743-754.
17. Cabello-Verrugio C., Santander C., Jofre C., Acuna M.J., Melo F., Brandan E. The internal region leucine-rich repeat 6 of decorin interacts with LRP-1, modulates TGF-beta dependent signaling and inhibits TGF-beta dependent fibrotic response in skeletal muscles. J Biol Chem 2012, 287:6773-6787.
18. Seidler D.G., Goldoni S., Agnew C., Cardi C., Thakur M.L., Owens R.T., McQuillan D.J., Iozzo R.V. Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation. J Biol Chem 2006, 281:26408-26418.
19. Goldoni S., Seidler D.G., Heath J., Fassan M., Baffa R., Thakur M.L., Owens R.T., McQuillan D.J., Iozzo R.V. An antimetastatic role for decorin in breast cancer. Am J Pathol 2008, 173:844-855.
20. Neill T., Painter H., Buraschi S., Owens R.T., Lisanti M.P., Schaefer L., Iozzo R.V. Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1alpha, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3. J Biol Chem 2012, 287:5492-5506.
21. Merline R., Moreth K., Beckmann J., Nastase M.V., Zeng-Brouwers J., Tralhao J.G., Lemarchand P., Pfeilschifter J., Schaefer R.M., Iozzo R.V., Schaefer L. Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21. Sci Signal 2011, 4:ra75.
22. Stock C., Jungmann O., Seidler D.G. Decorin and chondroitin-6 sulfate inhibit B16V melanoma cell migration and invasion by cellular acidification. J Cell Physiol 2011, 226:2641-2650.
23. Stock C., Gassner B., Hauck C.R., Arnold H., Mally S., Eble J.A., Dieterich P., Schwab A. Migration of human melanoma cells depends on extracellular pH and Na+/H+ exchange. J Physiol 2005, 567:225-238.
24. Paradise R.K., Lauffenburger D.A., Van Vliet K.J. Acidic extracellular pH promotes activation of integrin alpha(v)beta(3). PLoS One 2011, 6:e15746.
25. Fiedler L.R., Schönherr E., Waddington R., Niland S., Seidler D.G., Aeschlimann D., Eble J.A. Decorin regulates endothelial cell motility on collagen I through activation of insulin-like growth factor I receptor and modulation of alpha2beta1 integrin activity. J Biol Chem 2008, 283:17406-17415.
26. Marchica C.L., Pinelli V., Borges M., Zummer J., Narayanan V., Iozzo R.V., Ludwig M.S. A role for decorin in a murine model of allergen-induced asthma. Am J Physiol Lung Cell Mol Physiol 2011, 300:L863-L873.
27. Schaefer L., Macakova K., Raslik I., Micegova M., Grone H.J., Schönherr E., Robenek H., Echtermeyer F.G., Grässel S., Bruckner P., et al. Absence of decorin adversely influences tubulointerstitial fibrosis of the obstructed kidney by enhanced apoptosis and increased inflammatory reaction. Am J Pathol 2002, 160:1181-1191.
28. Yamaguchi Y., Mann D.M., Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 1990, 346:281-284.
29. Santra M., Santra S., Zhang J., Chopp M. Ectopic decorin expression up-regulates VEGF expression in mouse cerebral endothelial cells via activation of the transcription factors Sp1, HIF1alpha, and Stat3. J Neurochem 2008, 105:324-337.
30. Seidler D.G., Mohamed N.A., Bocian C., Stadtmann A., Hermann S., Schafers K., Schafers M., Iozzo R.V., Zarbock A., Gotte M. The role for decorin in delayed-type hypersensitivity. J Immunol 2011, 187:6108-6119.
31. Lee S., Bowrin K., Hamad A.R., Chakravarti S. Extracellular matrix lumican deposited on the surface of neutrophils promotes migration by binding to beta2 integrin. J Biol Chem 2009, 284:23662-23669.
32. Ferdous Z., Peterson S.B., Tseng H., Anderson D.K., Iozzo R.V., Grande-Allen K.J. A role for decorin in controlling proliferation, adhesion, and migration of murine embryonic fibroblasts. J Biomed Mater Res A 2010, 93:419-428.
33. Kresse H., Rosthoj S., Quentin E., Hollmann J., Glössl J., Okada S., Tonnesen T. Glycosaminoglycan-free small proteoglycan core protein is secreted by fibroblasts from a patient with a syndrome resembling progeroid 1. Am J Hum Genet 1987, 41:436-453.
34. Faiyaz-Ul-Haque M., Zaidi S.H., Al Ali M., Al Mureikhi M.S., Kennedy S., Al Thani G., Tsui L.C., Teebi A.S. A novel missense mutation in the galactosyltransferase-I (B4GALT7) gene in a family exhibiting facioskeletal anomalies and Ehlers-Danlos syndrome resembling the progeroid type. Am J Med Genet 2004, 128A:39-45.
35. Seidler D.G., Faiyaz-Ul-Haque M., Hansen U., Yip G.W., Zaidi S.H., Teebi A.S., Kiesel L., Götte M. Defective glycosylation of decorin and biglycan, altered collagen structure, and abnormal phenotype of the skin fibroblasts of an Ehlers-Danlos syndrome patient carrying the novel Arg270Cys substitution in galactosyltransferase I (beta4GalT-7). J Mol Med 2006, 84:583-594.
36. Götte M., Spillmann D., Yip G.W., Versteeg E., Echtermeyer F.G., van Kuppevelt T.H., Kiesel L. Changes in heparan sulfate are associated with delayed wound repair, altered cell migration, adhesion and contractility in the galactosyltransferase I (beta4GalT-7) deficient form of Ehlers-Danlos syndrome. Hum Mol Genet 2008, 17:996-1009.
37. Prydz K., Dalen K.T. Synthesis and sorting of proteoglycans 1. J Cell Sci 2000, 113:193-205.
38. Seidler D.G., Breuer E., Grande-Allen K.J., Hascall V.C., Kresse H. Core protein dependence of epimerization of glucuronosyl residues in galactosaminoglycans. J Biol Chem 2002, 277:42409-42416.
39. Herzog C., Lippmann I., Grobe K., Zamfir A.D., Echtermeyer F., Seidler D.G. The amino acid tryptophan prevents the biosynthesis of dermatan sulfate. Mol Biosyst 2011, 7:2872-2881.
40. Miyake N., Kosho T., Mizumoto S., Furuichi T., Hatamochi A., Nagashima Y., Arai E., Takahashi K., Kawamura R., Wakui K., et al. Loss-of-function mutations of CHST14 in a new type of Ehlers-Danlos syndrome. Hum Mutat 2010, 31:966-974.
41. Dündar M., Muller T., Zhang Q., Pan J., Steinmann B., Vodopiutz J., Gruber R., Sonoda T., Krabichler B., Utermann G., et al. Loss of dermatan-4-sulfotransferase 1 function results in adducted thumb-clubfoot syndrome. Am J Hum Genet 2009, 85:873-882.
42. Bian S., Akyuz N., Bernreuther C., Loers G., Laczynska E., Jakovcevski I., Schachner M. Dermatan sulfotransferase Chst14/D4st1, but not chondroitin sulfotransferase Chst11/C4st1, regulates proliferation and neurogenesis of neural progenitor cells. J Cell Sci 2011, 124:4051-4063.
43. Maccarana M., Olander B., Malmstrom J., Tiedemann K., Aebersold R., Lindahl U., Li J.P., Malmstrom A. Biosynthesis of dermatan sulfate: chondroitin-glucuronate C5-epimerase is identical to SART2. J Biol Chem 2006, 281:11560-11568.
44. Goossens D., Van G.S., Claes S., De R.P., Souery D., Massat I., Van den B.D., Backhovens H., Mendlewicz J., Van B.C., Del-Favero J. A novel CpG-associated brain-expressed candidate gene for chromosome 18q-linked bipolar disorder. Mol Psychiatry 2003, 8:83-89.
45. Maccarana M., Kalamajski S., Kongsgaard M., Magnusson S.P., Oldberg A., Malmstrom A. Dermatan sulfate epimerase 1-deficient mice have reduced content and changed distribution of iduronic acids in dermatan sulfate and an altered collagen structure in skin. Mol Cell Biol 2009, 29:5517-5528.
46. Rühland C., Schönherr E., Robenek H., Hansen U., Iozzo R.V., Bruckner P., Seidler D.G. The glycosaminoglycan chain of decorin plays an important role in collagen fibril formation at the early stages of fibrillogenesis. FEBS J 2007, 274:4246-4255.
47. Akatsu C., Mizumoto S., Kaneiwa T., Maccarana M., Malmstrom A., Yamada S., Sugahara K. Dermatan sulfate epimerase 2 is the predominant isozyme in the formation of the chondroitin sulfate/dermatan sulfate hybrid structure in postnatal developing mouse brain. Glycobiology 2011, 21:565-574.
48. Thelin M., Svensson K.J., Shi X., Bagher M., Axelsson J., Isinger-Ekstrand A., van Kuppevelt T.H., Johansson J., Nilbert M., Zaia J., et al. Dermatan sulfate is involved in the tumorigenic properties of Esophagus Squamous Cell Carcinoma. Glycobiology 2012, 22:1007-1016.
49. Zamfir A.D., Flangea C., Sisu E., Serb A.F., Dinca N., Bruckner P., Seidler D.G. Analysis of novel over- and under-sulfated glycosaminoglycan sequences by enzyme cleavage and multiple stage MS. Proteomics 2009, 9:3435-3444.
50. Zamfir A.D., Flangea C., Serb A., Sisu E., Zagrean L., Rizzi A., Seidler D.G. Brain chondroitin/dermatan sulfate, from cerebral tissue to fine structure: extraction, preparation, and fully automated chip-electrospray mass spectrometric analysis. Methods Mol Biol 2012, 836:145-159.
51. Leymarie N., McComb M.E., Naimy H., Staples G.O., Zaia J. Differential characterization and classification of tissue specific glycosaminoglycans by tandem mass spectrometry and statistical methods. Int J Mass Spectrom 2012, 312:144-154.
52. Scott P.G., McEwan P.A., Dodd C.M., Bergmann E.M., Bishop P.N., Bella J. Crystal structure of the dimeric protein core of decorin, the archetypal small leucine-rich repeat proteoglycan. Proc Natl Acad Sci U S A 2004, 101:15633-15638.